Videos

Take a closer look at some of our assays in our calprotectin product line. Learn more about IBDoc® and Quantum Blue®

IBDoc® Videos

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

Daily use of IBDoc® in clinical practice

ECCO 2020 interviews with Kathleen Sugrue from the Mercy University Hospital and Pearl Avery from the Dorset County Hospital about the daily use of IBDoc^® in clinical practice.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

Kathleen Sugrue about the daily use of IBDoc®

ECCO 2020 interview with Kathleen Sugrue about the daily use of IBDoc^® at the Mercy University Hospital.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

Pearl Avery about the daily use of IBDoc®

ECCO 2020 interview with Pearl Avery about the daily use of IBDoc^® at the Dorset County Hospital.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

Impact of IBDoc® in clinical practice

Kathleen Sugrue presented a study performed at the Mercy University Hospital, which assessed the impact of IBDoc^® in clinical practice.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

Efficacy of IBDoc® at Dorset County Hospital

Pearly Avery presented the findings of an internal audit, which was cunducted at Dorset County Hospital to evaluate the efficacy of IBDoc^® to better assess the benefit for patients and hospitals.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

Home testing devices for IBD

Two home testing devices measuring fecal calprotectin were compared to an ELISA test.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

Management of IBD using smarthphone apps

The management of IBD using the two different smartphone apps IBDoc^® and IBDsmart were compared.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

BÜHLMANN - IBDoc® Swiss Medtech Award 2018

At this year’s SwissMedtech Day, BÜHLMANN was nominated to receive the Swiss Medtech Award for presenting IBDoc^® to a Jury of medtech and academic reperesentatives. The jury nominated 3 projects for the Swiss Medtech Award 2018, BÜHLMANN Laboratories AG among them.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

IBDoc® Self-care/Point of care Calprotectin Test: Early Value in a District General Hospital

Pearl Avery from Dorset County Hospital shows very interesting data on the clinical validity and ease of use of the IBDoc® calprotectin home test.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

Interview Anke Heida, UMCG, ECCO 2017 Poster

Anke Heida from the Groningen Unversity Medical Center explains the poster published at the European Crohn’s and Colitis Congress.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

Interview Caroline Bello, CHU Liege, ECCO 2017 Poster

Caroline Bello from the Liège Center Hosptial Universitaire explains the poster published at the European Crohn’s and Colitis Congress.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

IBDoc® Interview with Christian Reinhard at UEGW

BÜHLMANN IBDoc^® Product Manager discusses recent market experience with the first CE marked calprotectin home test at United European Gastroenterology Week 2016 in Vienna.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

IBDoc® - Perspective from a Patient and Nurse

A patient and a nurse share their perspectives and experience with IBDoc^® at United European Gastroenterology Week 2016 in Vienna.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

IBDoc® Calprotectin Home Test from BÜHLMANN

An overview of IBDoc^® as a diagnostic device for the quantitative determination of calprotectin levels in stool samples for use as a Point-of-Care test or Home Test by the patient.

Quantum Blue® Videos

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

BÜHLMANN Quantum Blue® fCAL Tutorial

Demonstration of CALEX® Cap extraction and quantitative fecal calprotectin measurement using the Quantum Blue® fCAL rapid test technology.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

Pharmacist-led proactive therapeutic drug monitoring with infliximab (PROXIMO)

Dr. Rentsch from the Alfred Health Melbourne shows very promising data on infliximab management supported by the Quantum Blue® Infliximab rapid test and implications for therapy cost reduction.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

New biosimilar of infliximab SB2 can be quantified by IXF-optimized therapeutic drug monitoring

Joana Afonso from the University of Porto presents data that confirms the validated use of the Quantum Blue® Infliximab assay to quantify the new infliximab biosimilar SB2.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

Point-of-care infliximab quantification in inflammatory bowel disease in daily practice

Dr. Maria Pia Santos from the Beatriz Angelo Hospital presents data on an easy integration of the Quantum Blue® TDM rapid test in clinical routine.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

Using point of care testing for infliximab and fecal calprotectin in IBD patients with secondary LOR

Dr. Afif from McGill presents a pilot study for the Quantum Blue® Infliximab rapid test application in loss of response patients.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

Scientific Poster Quantum Blue® Infliximab

Thomas Schuster, PhD, presents his poster at the 11th ECCO congress about a new rapid test to measure infliximab trough levels on the BÜHLMANN Quantum Blue^® Platform.

You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

Accept required service and unblock content

BÜHLMANN Quantum Blue® fCAL – Calprotectin POC

A brief overview of BÜHLMANN Laboratories and their product portfolio as well as an introduction to Calprotectin measurement on BÜHLMANN’s Quantum Blue^® fCAL assays.

Explore BÜHLMANN ‘s full list of video resources.

Watch more videos